Loading
MYCL (MYCL proto-oncogene, bHLH transcription factor) is a gene. The public catalogues list it as a drug target and a biomarker, and clinical evidence ties its variants to diagnosis, prognosis or drug response. Tied to Multiple myeloma, Skin cancer and Melanoma. This dossier gathers the 0 products (0 approved), 0 trials, 0 pathways and 0 resistance routes in the corpus that involve it, with external identifiers so it can be joined to UniProt, ChEMBL, Open Targets and the rest of biology.
UniProt has no function text for P12524; HGNC names it "MYCL proto-oncogene, bHLH transcription factor". Location: Nucleus (UniProt). Locus 1p34.2 (HGNC).
No product in the corpus is aimed at this target yet.
No trial in the corpus names this target or one of its products.
No recorded escape route names this target.
No pathway diagram carries this target as a node.
No companion diagnostic in the registry measures this target.
No model entry for this target yet; check the cancer entries on the models page.
No open questions recorded for this target yet. Suggest one.
Query for this target: (TITLE:"MYCL" OR ABSTRACT:"MYCL" OR TITLE:"MYCL proto-oncogene, bHLH transcription factor" OR ABSTRACT:"MYCL proto-oncogene, bHLH transcription factor" OR TITLE:"bHLHe38" OR ABSTRACT:"bHLHe38" OR TITLE:"MYCL1" OR ABSTRACT:"MYCL1") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about MYCL, not a curated reading list.
The dossier as machine-readable JSON, at /api/v1/dossiers/mycl.json: identifiers from HGNC, Ensembl, UniProt and ChEMBL, products with status, trials, pathways, hotspots, open questions and assays. The full entity record is in the open API at /api/v1/entities/mycl.json. Licence CC BY-NC 4.0.